| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 4,615,000 | 4,244,000 | 4,147,000 | 4,672,000 | | Cost of Revenue | 3,888,000 | 3,966,000 | 4,143,000 | 4,249,000 | | | Gross Profit | 727,000 | 278,000 | 4,000 | 423,000 | | | Operating Expenses | | Research Development | 39,000 | 38,000 | 41,000 | 52,000 | | Selling General and Administrative | 234,000 | 240,000 | 244,000 | 250,000 | | Non Recurring | 17,000 | 82,000 | 69,000 | 856,000 | | Others | 342,000 | 317,000 | 283,000 | 278,000 | | | | Total Operating Expenses | 632,000 | 677,000 | 637,000 | 1,436,000 | | | | Operating Income or Loss | 95,000 | (399,000) | (633,000) | (1,013,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 101,000 | 111,000 | (30,000) | 56,000 | | Earnings Before Interest And Taxes | 218,000 | (310,000) | (663,000) | (976,000) | | Interest Expense | 120,000 | 115,000 | 114,000 | 124,000 | | Income Before Tax | 98,000 | (425,000) | (777,000) | (1,100,000) | | Income Tax Expense | (22,000) | (108,000) | (307,000) | (211,000) | | Minority Interest | 5,000 | 5,000 | (10,000) |
-
| | | | Net Income From Continuing Ops | 125,000 | (312,000) | (480,000) | (889,000) | | | Non-recurring Events | | Discontinued Operations | 4,000 | (142,000) | (17,000) | (302,000) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 129,000 | (454,000) | (497,000) | (1,191,000) | | Preferred Stock And Other Adjustments | (52,000) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $77,000 | ($454,000) | ($497,000) | ($1,191,000) |
|
0.29% Nasdaq 
Income Statement
